CLINICAL TRIAL PATIENT TECHNOLOGY INSIGHTS
-
Edge AI Is Reshaping How Clinical Trials Run
Edge computing and AI are transforming clinical trials – enabling real time monitoring, decentralized research, and faster, more cost-effective drug development.
-
Telehealth In Clinical Trials: What Sites And Patients Think
Sites and patients have complicated views on telehealth in trials. Here’s what the evidence shows about who benefits, who bears the burden, and where the limits are.
ECOA RESOURCES
-
TrialKit addresses data management issues in clinical trials through its innovative ePRO and eCOA tools, which facilitate real-time data collection and reporting.
-
Dive into the prediction that the rapid adoption of eCOAs will continue to grow in 2022, as sponsors acknowledge how useful these tools have become in decentralized clinical trial (DCT) settings.
-
Learn why sponsors should implement an integrated data monitoring plan and technology solution to ensure data integrity, meet evolving regulatory requirements, and improve trial outcomes.
ECONSENT RESOURCES
-
See how a team of four managed data for 40 peer-reviewed studies and 200,000 participants.
-
Delve into the preferences of patients and caregivers in the field of oncology, specifically regarding eConsent, telehealth, wearables, and other digital technologies.
-
In this presentation, Dr. Christine Senn addresses the persistent challenge of study startup delays by focusing on a primary legal hurdle: the Confidential Disclosure Agreement (CDA).
EPRO RESOURCES
-
TrialKit addresses data management issues in clinical trials through its innovative ePRO and eCOA tools, which facilitate real-time data collection and reporting.
-
Dive into the prediction that the rapid adoption of eCOAs will continue to grow in 2022, as sponsors acknowledge how useful these tools have become in decentralized clinical trial (DCT) settings.
-
In this presentation, a distinguished panel of experts illuminates the crucial role of patient-reported outcomes (PROs) in shaping regulatory decisions and drug development strategies.